Company Analysis SUSMED,Inc.
1. Summary
Advantages
- Price (652 Β₯) is less than fair price (1274.93 Β₯)
- The company's current efficiency (ROE=-7.54%) is higher than the sector average (ROE=-9.19%)
Disadvantages
- Dividends (0%) are below the sector average (2.66%).
- The stock's return over the last year (-53.69%) is lower than the sector average (-0.4409%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| SUSMED,Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.3% | -0% | 3.9% |
| 90 days | 8.8% | -0% | 3.4% |
| 1 year | -53.7% | -0.4% | 10.2% |
4263 vs Sector: SUSMED,Inc. has significantly underperformed the "Healthcare" sector by -53.25% over the past year.
4263 vs Market: SUSMED,Inc. has significantly underperformed the market by -63.92% over the past year.
Stable price: 4263 is not significantly more volatile than the rest of the market on "Tokyo Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 4263 with weekly volatility of -1.03% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (652 Β₯) is lower than the fair price (1274.93 Β₯).
Price significantly below the fair price: The current price (652 Β₯) is 95.5% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (110.63).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (121.09).
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.11) is lower than that of the sector as a whole (70.3).
P/BV vs Market: The company's P/BV (2.11) is lower than that of the market as a whole (88.19).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (28.36) is lower than that of the sector as a whole (75.01).
P/S vs Market: The company's P/S indicator (28.36) is lower than that of the market as a whole (88.15).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-13.56) is lower than that of the sector as a whole (18.64).
EV/Ebitda vs Market: The company's EV/Ebitda (-13.56) is lower than that of the market as a whole (94.73).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 53.77% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (53.77%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (3.56%).
5.4. ROE
ROE vs Sector: The company's ROE (-7.54%) is higher than that of the sector as a whole (-9.19%).
ROE vs Market: The company's ROE (-7.54%) is lower than that of the market as a whole (7.67%).
5.5. ROA
ROA vs Sector: The company's ROA (-7.12%) is higher than that of the sector as a whole (-9.6%).
ROA vs Market: The company's ROA (-7.12%) is lower than that of the market as a whole (3.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (9.09%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (8.77%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.66%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
